AD/PD™ 2015 Showcases the Latest Research and New Therapies in Alzheimer's, Parkinson's and Related Brain Diseases

GENEVA, March 16, 2015 /PRNewswire/ --

The world's neurodegenerative disease specialists are gathering March 18-22, 2015 in Nice, France at the premier showcase for the latest research and scientific discoveries in neurodegenerative diseases: AD/PD™ 2015.

AD/PD™ 2015, the 12^th International Conference on Alzheimer's and Parkinson's Disease, co-organized by Abraham Fisher, Roger Nitsch and Manfred Windisch, is a landmark event bringing together over 3,000, neuroscientists, pharmacologists and clinicians to study the hot topics, similarities and differences and scientific breakthroughs associated with Alzheimer's Disease, Parkinson's Disease and related neurological disorders, and to evaluate advances that might ameliorate many of these diseases.

Speakers include Nobel Prize Laureates Elizabeth Blackburn, Tom Südhoff and Ada Yonath, as well as a large faculty of the world's premier experts in neuroscience and brain diseases complemented by a vibrant community of young emerging investigators who are on their ways to shape the future of this field.

Cutting edge scientific breakthroughs presented at AD/PD™ 2015 will include emerging technologies for manipulating the immune response to treat neurological diseases, novel molecular brain imaging technologies and biomarkers of disease. New insights into disease mechanisms include seeding and spreading of misfolded proteins, as well as epigenetic and genetic effects in neurodegenerative diseases. The role of receptors and enzymes as potential novel therapeutic targets is going to be discussed.

"AD/PD™ combines all the neurodegenerative diseases under one roof," said Dr. Abraham Fisher, the President of AD/PD™ 2015. "It is the main platform for the world's experts to present their latest findings and research  in diagnosis, prevention and discovery of new treatment targets for these debilitating disorders."

The multidisciplinary scientific program consists of the three main tracks "Treatment Strategies", "Basic Science" and "Clinical Studies". Major sessions are devoted to clinical aspects in Alzheimer's disease, Parkinson's disease and related brain diseases. A Podium Discussion will assess if standardization can improve the predictive value of animal models. The meeting will conclude with a Podium Discussion by world renowned experts exploring strategies to mitigate the high attrition rate in current drug development in order to shape the future of clinical practice with disease-modifying drugs.  

About AD/PD™:  Neurodegenerative diseases are a serious health challenge facing all societies with aging demographics.  Founded in 1985 by Abraham Fisher and Israel Hanin, AD/PD™ conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their integration.  AD/PD™ is now the world's foremost platform devoted to promoting the latest advances in neurodegenerative disease research and new therapies.  

Contact Information:
Onsite Contact: Jonathan Maron, [email protected]
AD/PD™ 2015, Kenes International, Rue François-Versonnex 7; C.P. 6053, 1211 Geneva 6, Switzerland,
AD/PD™ Secretariat Email: [email protected]

SOURCE AD/PD(TM)